SMTL ID : 5cao.1

EGFR kinase domain mutant "TMLR" with compound 29

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x 4ZG: N~2~-[2-methyl-2-(methylsulfonyl)propyl]-N~4~-[2-methyl-1-(propan-2-yl)-1H-imidazo[4,5-c]pyridin-6-yl]pyrimidine-2,4-diamine(Non-covalent)

4ZG.1: 15 residues within 4Å: Chain A: L.25, G.26, F.30, A.50, K.52, M.73, C.82, M.97, Q.98, L.99, M.100, G.103, L.151, T.161, D.162 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.25, A:F.30, A:M.97 Hydrogen bonds: A:Q.98, A:M.100, A:T.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heald, R. et al., Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study. J.Med.Chem. (2015)

Release Date

2015-10-28

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence